Actual Medicinal Product (AMP) Vesicare 5mg tablets (Pharmaram Ltd)
This product can't be added to an MCA list.
Stability Information
(Some stability information inherited from generic)
- Stability
-
Lack of data and/or stability concerns exist. MCA use may be acceptable but is likely to be off-label and require mitigation measures. Keep medicines in MCAs for the shortest time necessary. Generally, up to 5 weeks maximum unless otherwise specified, or up to 8 weeks if the MCA is airtight (sealed). Consider the risk of potency loss or dose variability and monitor for changes in efficacy or adverse effects after MCA initiation.
- Notes
-
Protect from moisture.
No stability data in MCAs available. - Provenance
-
This recommendation is based on the products Vesicare 5mg film-coated tables (Astellas Pharma Ltd) and Solifenacin 5mg film-coated tablets (Aurobindo Pharma – Milpharm Ltd).
- Generic
- Solifenacin
- Formulation
- Solifenacin 5mg tablets
-
Solifenacin
-
Solifenacin 5mg tablets
-
Vesicare 5mg tablets (Pharmaram Ltd)
-
-